Related Experiment Video

Updated: May 16, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

[Safe transportation of children: what is our responsibility as pediatricians?]

Luis Arturo Agote Robertson1

  • 1laagote@fibertel.com.ar

Archivos Argentinos De Pediatria
|December 11, 2012
PubMed

Insights

In Argentina, 564 children died in traffic accidents in 2009. Using appropriate child safety seats could prevent most child fatalities in car accidents.

Area of Science:

  • Pediatric Traumatology
  • Public Health
  • Road Safety Engineering

Context:

  • Argentina experienced 564 child traffic accident fatalities in 2009.
  • The child mortality rate from road accidents in Argentina is significantly higher than in countries like Sweden.
  • Vulnerable age groups include infants under one year and children aged 1-6 years.

Purpose:

  • To analyze child mortality data from traffic accidents in Argentina.
  • To highlight the effectiveness of child safety seats in preventing fatalities.
  • To advocate for improved safety measures and public awareness campaigns.

Summary:

  • 50% of child fatalities occurred in cars, 30% in heavy-duty vehicles, 16.3% during vehicle rollovers, and 4.5% on two-wheeled vehicles.
  • Serious injuries and deaths are disproportionately higher among infants.
  • An estimated 71% of infants and 54% of children aged 1-6 could survive accidents if using proper safety restraints.

Impact:

  • Implementing mandatory child safety seat usage can drastically reduce child mortality in traffic accidents.
  • Collaboration between healthcare professionals (obstetricians, pediatricians) and state institutions is crucial for effective safety campaigns.
  • Public awareness and education on the correct use of safety seats are vital for saving young lives.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...